An overview of FDA-approved new molecular entities: 1827–2013
Top Cited Papers
- 1 August 2014
- journal article
- research article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 19 (8), 1033-1039
- https://doi.org/10.1016/j.drudis.2014.03.018
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- COX-2 Inhibition: What We Learned—A Controversial Update on Safety DataPain Medicine, 2013
- Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009Clinical Pharmacology & Therapeutics, 2010
- Deconstructing the Drug Development Process: The New Face of InnovationClinical Pharmacology & Therapeutics, 2010